慢性静脉疾病的临床病程:基于电子健康记录的大样本回顾性研究
本研究利用电子健康记录(EHR)对890 982例慢性静脉疾病(CVD)患者进行回顾性纵向分析,并嵌套病例对照研究,采用机器学习方法评估CVD发生相关因素。结果显示静脉曲张(VV)与静脉性溃疡(VLU)表型不同,仅1-2%的VV患者进展为VLU,VLU患者死亡率显著增高。
要点
- 静脉曲张与静脉性溃疡具有不同的表型特征和相关因素。
- 仅1-2%的静脉曲张患者进展为静脉性溃疡,中位时间7年。
- 静脉性溃疡患者死亡率较匹配对照组显著增高。
核心结论
- 静脉曲张与静脉性溃疡表型不同,仅小部分静脉曲张患者进展为溃疡,需考虑其他病因因素解释临床异质性。
研究设计与样本
- 回顾性纵向研究,基于国家数据库电子健康记录,纳入890 982例病例,并嵌套病例对照研究,采用机器学习方法分析。
主要发现
- 静脉曲张与超重(OR 1.12,95%CI 1.04-1.20)、既往妊娠(OR 5.83,95%CI 4.37-7.79)和激素治疗(OR 2.13,95%CI 1.75-2.58)相关。
- 静脉性溃疡与白人种族(OR 21.54,95%CI 3.80-122.17)、男性(p < .001)、肥胖(OR 1.46,95%CI 1.20-1.79)、衰弱(OR 1.77,95%CI 1.51-2.09)和既往静脉血栓栓塞(OR 3.07,95%CI 2.49-3.78)相关。
- 心血管疾病如冠心病(OR 20.05,95%CI 14.09-28.55)和高胆固醇血症(OR 3.76,95%CI 3.18-4.45)与CVD风险增加相关,维生素D缺乏(OR 1.52,95%CI 1.31-1.76)与静脉性溃疡相关。
- 1-2%的静脉曲张患者进展为静脉性溃疡(中位7年),23%的静脉性溃疡患者出现溃疡复发(中位复发时间207天)。
- 与匹配对照组相比,静脉性溃疡患者死亡风险增加(HR 1.39,95%CI 1.23-1.58);中位随访11.5年时,静脉性溃疡组死亡率28%,对照组7.3%(p < .001)。
临床怎么用
- 应认识到静脉曲张与静脉性溃疡表型不同,对静脉曲张患者进行个体化评估和随访。
- 静脉性溃疡患者需关注心血管合并症、衰弱和既往静脉血栓栓塞,并警惕死亡率增高风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The clinical manifestations of chronic venous disease (CVD) range from varicose veins (VV) to, ultimately, venous ulceration, representing a spectrum of disease states. This study aimed to evaluate the clinical course of CVD using electronic healthcare records (EHRs). METHODS: A retrospective, longitudinal study evaluating data from EHRs gathered from national databases, with a nested case control study, was performed to evaluate factors associated with CVD development. Analytics were performed using machine learning methods. RESULTS: The study population comprised 890 982 cases. VV were associated with being overweight (odds ratio [OR] 1.12, 95% confidence interval [CI] 1.04 - 1.20), a previous pregnancy (OR 5.83, 95% CI 4.37 - 7.79), and hormonal therapies (OR 2.13, 95% CI 1.75 - 2.58). Venous ulceration (VLU) was associated with White ethnicity (OR 21.54, 95% CI 3.80 - 122.17), men (p < .001), obesity (OR 1.46, 95% CI 1.20 - 1.79), frailty (OR 1.77, 95% CI 1.51 - 2.09), and previous venous thromboembolism (OR 3.07, 95% CI 2.49 - 3.78). An increased OR of CVD was found with cardiovascular conditions such as coronary artery disease (OR 20.05, 95% CI 14.09 - 28.55) and hypercholesterolaemia (OR 3.76, 95% CI 3.18 - 4.45). Biochemical markers, such as vitamin D deficiency (OR 1.52, 95% CI 1.31 - 1.76), were associated with VLU. Regarding disease progression, 1 - 2% of patients presenting with VV went on to develop VLU (median 7 years); 23% of patients with VLU developed ulcer recurrence; median time to recurrence was 207 days. Compared with a matched control group, VLU led to an increased risk in mortality (hazard ratio 1.39, 95% CI 1.23 - 1.58). At median follow up (11.5 years), mortality was significantly higher in VLU participants (28%) compared with control participants (7.3%; p < .001). CONCLUSION: There are common factors associated with the different clinical manifestations of CVD. However, participants with VV and VLU appear to be phenotypically distinct, with only a small proportion of patients with VV developing VLU. Other aetiological factors should be considered when understanding why superficial venous reflux can manifest in clinically heterogenous ways.
引用
- Salim S, Machin M, Mazidi M, et al. The Clinical Course of Chronic Venous Disease. Eur J Vasc Endovasc Surg. 2026. PMID: 42556557. doi:10.1016/j.ejvs.2026.07.065
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。